Poster preliminary proof-of-concept studies

Poster preliminary proof-of-concept studies

Barcelona – 2A Pharma presents poster at the World Vaccine Congress Europe During the World Vaccine Congress Europe, we presented more details about our preliminary proof-of-concept studies and the development of the active vaccine against EpCAM+ cancers, which...
Jeanette Prangsgaard speaks about clinical trials

Jeanette Prangsgaard speaks about clinical trials

On November 4, Jeanette Prangsgaard held a presentation at the ‘Clinical Trials’ even, organised by Synapse – Life Science Connect Aalborg. Jeanette spoke about clinical trials, what they entail, and what her role is in the process of the development of our...